Year: - Any -201920182017201620152014 Items per page 102550 August 8, 2016 - Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer June 23, 2016 - Apellis Announces Positive Results from Phase 1 Clinical Trials of APL-2, a C3 Complement Inhibitor
